| # | Drug | Count |
|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 64 |
| 1 | ADALIMUMAB | 19 |
| 2 | PREDNISONE | 15 |
| 3 | RITUXIMAB | 15 |
| 4 | IMMUNE GLOBULIN | 14 |
| 5 | OCRELIZUMAB | 14 |
| 6 | METHOTREXATE | 13 |
| 7 | METHOTREXATE SODIUM | 13 |
| 8 | METHYLPREDNISOLONE | 12 |
| 9 | PREDNISOLONE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 1 | HUMAN IMMUNOGLOBULIN G | 64 | 0.0031 |
| 2 | RITLECITINIB | 6 | 0.0031 |
| 3 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 4 | PYRIDOSTIGMINE BROMIDE ORAL | 5 | 0.0014 |
| 5 | FENOFIBRIC ACID | 1 | 0.0013 |
| 6 | ABROCITINIB | 4 | 0.0010 |
| 7 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 8 | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE | 1 | 0.0009 |
| 9 | FOSNETUPITANT AND PALONOSETRON | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 87 |
| 1 | Corticosteroid [EPC] | 44 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 30 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 15 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 6 | Vitamin C [EPC] | 13 |
| 7 | Vitamin B12 [EPC] | 12 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Proton Pump Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 87 | 0.0041 |
| 1 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 2 | Bismuth [EPC] | 2 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Antimycobacterial [EPC] | 6 | 0.0002 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0002 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 8 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |